Cabinet to assess 20 drugs in 2016 under new rules

Ministers charged with making life or death calls

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
28th August, 2016
HSE director general Tony OBrien Pic: RollingNews.ie

Twenty expensive new medicines are expected to go to cabinet for approval this year, the Department of Health has said.

Under a radically changed approval process, the government now has to approve expensive medicines before the Health Service Executive (HSE) will pay for them.

New drugs to treat cancer, high cholesterol and cystic fibrosis are at various stages of the assessment process at present. The cumulative cost of these medicines is about €300 million per...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Healthcare software developers claim they could cut waiting lists by 25%

Health Rachel Lavin 4 days ago

Tony O’Brien: The apparent slow collapse of Sláintecare deserves more than a shrug of the shoulders

Health Tony O'Brien 5 days ago

‘Reinforcing’ of existing HSE structures played role in Sláintecare resignations

Health Daniel Murray 5 days ago

HSE never used Citywest conference centre as isolation hub despite multimillion refurbishment

Health Donal MacNamee 1 week ago